Join the Oncology Voice Network. Join for Free
Season 2, Episode 6: Mentorship and Career Growth with Josh Schwartz

Season 2, Episode 6: Mentorship and Career Growth with Josh Schwartz


Share This Article


Welcome back to another fantastic episode of the Pharmaverse podcast!

This week our host Michael Pietrack interviews Josh Schwartz, MD MBA, Vice President of Medical Affairs North America at BeOne ( formerly BeiGene.) They discuss the importance of leadership in the pharmaceutical industry, focusing on developing others, the journey from individual contributor to manager, and the qualities that make an effective leader. Schwartz shares insights on mentorship, the coaching tree concept, and the five Cs of leadership: caring, communication, culture, challenge, and career development. He emphasizes the significance of treating people well, being authentic, and continuously seeking feedback to grow as a leader. Tune in for a great episode on Leadership, Mentorship and career growth with a phenomenal Pharma leader.

Takeaways 🔑

👌Developing other people is crucial for leadership.

📈The journey from individual contributor to manager can be rapid if the opportunity arises.

👀Observing both good and bad leaders provides valuable lessons.

💞Caring and communication are foundational to effective leadership.

🤝Creating a supportive culture is essential for team success.

📚 Career development should be a priority for leaders.

👨‍🏫 Mentorship can significantly impact career growth.

📑A good mentor is a mentor for life. 

🎉Hiring non-traditional leaders can bring fresh perspectives.

💪Aspiring leaders should treat people well, be themselves, and work hard.

Watch on YouTube

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2
OVN Avatar Guillaume Beinse, MD, Virgile Tellier, Valentin Charvet, MSc, Eric Deutsch, MD, PhD, Isabelle Borget, PharmD, PhD, Christophe Massard, MD, PhD., Antoine Hollebecque, MD, PhD, and Loic Verlingue, MD

Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2

Article
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
OVN Avatar Laleh Amiri-Kordestani & Richard Pazdur

Oncology approvals in 2020: a year of firsts in the midst of a pandemic

Article
Real-World Evidence in Oncology: Opportunities and Limitations
OVN Avatar Massimo Di Maio, Francesco Perrone, Pierfranco Conte

Real-World Evidence in Oncology: Opportunities and Limitations

Article
Accelerated drug approvals in oncology: Pros and cons
OVN Avatar Thakur, Sayanta & Lahiry, Sandeep

Accelerated drug approvals in oncology: Pros and cons

Article
Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives
OVN Avatar Jaques van Heerden, MD, Mohamed Zaghloul, MD, Anouk Neven, MSc, Teresa de Rojas, MD, PhD, Jennifer Geel, MD, Catherine Patte, MD, Joyce Balagadde-Kambugu, MD, Peter Hesseling, MD, Francine Tchintseme, MD, Eric Bouffet, MD, and Laila Hessissen, MD

Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives

Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Explore OVN